Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,197 | Dovepress* | 11,435+ | 1,257 | 12,692 | |
| PubMed Central* | 762 | 240 | 1,002 | ||
| Totals | 12,197 | 1,497 | 13,694 | ||
| *Since 16 November 2018 | |||||
View citations on PubMed Central and Google Scholar